Burcon NutraScience Corporation
BU.TOTSXConsumer Defensive● Active
$1.98
+$0.09(+4.76%)
Market Cap$25130706
P/E Ratio—
52W High$5
52W Low$1.51
Burcon NutraScience Corporation (BU.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BU.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 11, 2026EPS Actual
-$0.28
Est. -$0.04 · -600.0%
Revenue
$0.00B
Est. $0.00B · -26.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 11, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
BU.TO reports quarterly as a TSX-listed Packaged Foods company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 1, 2026 | -$0.10 | — | — | — | $0.00B | — |
| ◌ Q3 FY2026 | Jul 1, 2026 | -$0.10 | — | — | — | $0.00B | — |
| ▼ Q1 FY2026 | Feb 11, 2026 | -$0.04 | -$0.28 | -600.0% | $0.00B | $0.00B | -26.1% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.05 | -$0.28 | -466.4% | $0.00B | $0.00B | -64.3% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.07 | -$0.23 | -228.6% | $0.00B | $0.00B | +71.1% |
| ▼ Q2 FY2025 | Jun 25, 2025 | -$0.01 | -$0.34 | -4011.3% | $0.00B | $0.00B | -95.4% |
| — Q1 FY2025 | Feb 14, 2025 | -$0.01 | -$0.01 | +0.0% | $0.00B | $0.00B | -93.2% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.01 | -$0.02 | -100.0% | $0.00B | $0.00B | -93.3% |
Q3 FY2026
Jul 1, 2026
EPS Actual
—
EPS Est.
-$0.10
EPS Surpr.
—
Revenue
—
Q3 FY2026
Jul 1, 2026
EPS Actual
—
EPS Est.
-$0.10
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 11, 2026Miss
EPS Actual
-$0.28
EPS Est.
-$0.04
EPS Surpr.
-600.0%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.28
EPS Est.
-$0.05
EPS Surpr.
-466.4%
Revenue
$0.00B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.23
EPS Est.
-$0.07
EPS Surpr.
-228.6%
Revenue
$0.00B
Q2 FY2025
Jun 25, 2025Miss
EPS Actual
-$0.34
EPS Est.
-$0.01
EPS Surpr.
-4011.3%
Revenue
$0.00B
Q1 FY2025
Feb 14, 2025
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-100.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.13 | $0.13 | $0.13 | 1 |
| Q4 FY2027 | $0.11 | $0.11 | $0.11 | 1 |
| Q3 FY2027 | $0.08 | $0.08 | $0.08 | 1 |
| Q2 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q1 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2026 | $-0.03 | $-0.03 | $-0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 11, 2026 | -600.0% | $1.84 | $1.88 | +2.17% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -466.4% | $2.29 | $2.29 | +0.00% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -228.6% | $2.99 | $2.90 | -3.01% |
| ▼ Q2 FY2025 | Jun 25, 2025 | -4011.3% | $4.75 | $4.27 | -10.11% |
| ▲ Q1 FY2025 | Feb 14, 2025 | +0.0% | $2.00 | $2.00 | +0.00% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -100.0% | $2.70 | $2.80 | +3.70% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +97.9% | $3.90 | $3.80 | -2.56% |
| ▲ Q2 FY2024 | Jun 26, 2024 | +63.2% | $4.60 | $4.60 | +0.00% |
Q1 FY2026+2.17%
Report Date
Feb 11, 2026
EPS Beat/Miss
-600.0%
Price Before
$1.84
Price After
$1.88
Q4 FY2025+0.00%
Report Date
Nov 12, 2025
EPS Beat/Miss
-466.4%
Price Before
$2.29
Price After
$2.29
Q3 FY2025-3.01%
Report Date
Aug 12, 2025
EPS Beat/Miss
-228.6%
Price Before
$2.99
Price After
$2.90
Q2 FY2025-10.11%
Report Date
Jun 25, 2025
EPS Beat/Miss
-4011.3%
Price Before
$4.75
Price After
$4.27
Q1 FY2025+0.00%
Report Date
Feb 14, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.00
Price After
$2.00
Q4 FY2024+3.70%
Report Date
Nov 14, 2024
EPS Beat/Miss
-100.0%
Price Before
$2.70
Price After
$2.80
Q3 FY2024-2.56%
Report Date
Aug 14, 2024
EPS Beat/Miss
+97.9%
Price Before
$3.90
Price After
$3.80
Q2 FY2024+0.00%
Report Date
Jun 26, 2024
EPS Beat/Miss
+63.2%
Price Before
$4.60
Price After
$4.60
Avg Beat Reaction-0.85%
Avg Miss Reaction-1.45%
Beat Rate3 / 8 quarters
Largest Move-10.11% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BU.TO ends December
Burcon NutraScience Corporation (BU.TO) most recently reported earnings on February 11, 2026 for Q1 FY2026, posting EPS of $-0.28 — missing the analyst consensus of $-0.04 by -600.0%. The next BU.TO earnings date is expected around September 1, 2026.
Each quarter, investors track BU.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BU.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BU.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BU.TO earnings · 5 questionsBurcon NutraScience Corporation's next earnings report is expected around September 1, 2026. BU.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BU.TO historically reports after market close (AMC).
BU.TO earnings datewhen is BU.TO earningsBU.TO next earnings datewhen does BU.TO report earningsBU.TO earnings calendar
▸ Source: FMP · Burcon NutraScience Corporation SEC filings · US GAAP · Burcon NutraScience Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026